Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_44993 | 102 | 2.13 | Mlig455_068082 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.499 Region-enriched R4: 3.035/0.03492 |
MEN1 | Mlig455_068082 {REF} {Length: 4679} {TRANSSPLICED} {Pfam: Menin [PF05053.15, score=359.0]} {Human: ENSG00000133895, MEN1, menin 1, [RH, Score=259, Expect=6e-77]} {Mouse: ENSMUSG00000024947, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]; ENSMUSG00000106695, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]} {Dmel: FBgn0031885, Mnn1, Menin 1, [RH, Score=219, Expect=4e-61]} {Smed: dd_Smed_v6_11544_0_1, dd_Smed_v6_11544_0_1, [RH, Score=206, Expect=2e-56]} {RNA1509_25186} {RNA1310_10581.1} {RNA815_3602} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.909 | 1.968 | 0.99970 | 1.00000 | |
RegionR2 | -0.15 | 1.968 | 0.79837 | 1.00000 | |
RegionR3 | 0.442 | 1.968 | 0.62065 | 1.00000 | |
RegionR4 | 3.035 | 1.968 | 0.00476 | 0.03492 | |
RegionR5 | 0.522 | 1.968 | 0.59153 | 0.94938 | |
RegionR6 | 1.564 | 1.968 | 0.16341 | 0.71770 | |
RegionR7 | 2.168 | 1.968 | 0.07662 | 0.53405 | |
RegionR8 | -3.672 | 1.968 | 0.99987 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.743 | 1.968 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.143 | 1.968 | 0.82468 | 0.99592 | |
RegenerationR3 | 0.076 | 1.968 | 0.91469 | 1.00000 | |
RegenerationR4 | -1.236 | 1.968 | 0.08320 | 0.45626 | |
RegenerationR5 | 0.607 | 1.968 | 0.40546 | 0.80252 | |
RegenerationR6 | -0.487 | 1.968 | 0.50191 | 0.80743 | |
RegenerationBL | 0.241 | 1.968 | 0.73702 | 1.00000 | |
RegenerationTP | 0.87 | 1.968 | 0.62693 | 0.97562 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_44993 | 102 | 2.13 | Mlig455_068082 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.499 Region-enriched R4: 3.035/0.03492 |
MEN1 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_068082 {REF} {Length: 4679} {TRANSSPLICED} {Pfam: Menin [PF05053.15, score=359.0]} {Human: ENSG00000133895, MEN1, menin 1, [RH, Score=259, Expect=6e-77]} {Mouse: ENSMUSG00000024947, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]; ENSMUSG00000106695, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]} {Dmel: FBgn0031885, Mnn1, Menin 1, [RH, Score=219, Expect=4e-61]} {Smed: dd_Smed_v6_11544_0_1, dd_Smed_v6_11544_0_1, [RH, Score=206, Expect=2e-56]} {RNA1509_25186} {RNA1310_10581.1} {RNA815_3602} |
2. | MligTC455_25374 | 428 | 8.91 | Mlig455_036389, Mlig455_036390, Mlig455_036391, Mlig455_054557 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=1.690 Regeneration-upregulated BL: 5.459 Regeneration-enriched BL: 5.459 |
1.819 | - | - | - | 0.859 | - | 0.960 | Mlig455_036389 {REF} {Length: 860} {NoTransDecoderORF} {RNA1509_40044} {RNA1310_33232} {RNA815_16463} Mlig455_036390 {REF} {Length: 5024} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1} Mlig455_036391 {REF} {Length: 3445} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1} Mlig455_054557 {REF} {Length: 6330} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1} |
|
3. | MligTC455_38019 | 32 | 0.66 | Mlig455_052061 | Neo: - Age: - |
1.813 | - | - | - | 0.852 | - | 0.961 | Mlig455_052061 {REF} {Length: 1614} {NoTransDecoderORF} {RNA1509_22316} {RNA1310_86084} {RNA815_47119} | |
4. | MligTC455_10554 | 573 | 11.93 | Mlig455_037747, Mlig455_069922 | Neo: - Age: - Regeneration-depleted BL: -4.357 |
1.777 | - | - | - | 0.795 | - | 0.982 | Mlig455_037747 {REF} {Length: 601} {RNA1509_11182} {RNA1310_30933} {RNA815_1577.1} Mlig455_069922 {REF} {Length: 929} {RNA1509_11182} {RNA1310_9907, RNA1509_11182} {RNA1509_11182, RNA815_1577.1} |
|
5. | MligTC455_28655 | 49 | 1.03 | Mlig455_048319 | Neo: - |
RNF213 | 1.745 | - | - | - | 0.788 | - | 0.957 | Mlig455_048319 {REF} {Length: 12875} {Pfam: ATPase family associated with various cellular activities (AAA) [PF00004.31, score=25.3]; AAA domain (dynein-related subfamily) [PF07728.16, score=23.1]} {Human: ENSG00000173821, RNF213, ring finger protein 213, [Score=329, Expect=5e-89]} {Mouse: ENSMUSG00000070327, Rnf213, ring finger protein 213, [Score=319, Expect=3e-86]} {RNA1509_30363} {RNA1310_550} {RNA815_15} |
6. | MligTC455_40995 | 39 | 0.82 | Mlig455_050157 | Neo: - Age: - |
1.659 | - | - | - | 0.706 | - | 0.953 | Mlig455_050157 {REF} {Length: 1486} {NoTransDecoderORF} {RNA1509_60145} {RNA1310_75426} {RNA815_3903.1} | |
7. | MligTC455_51285 | 53 | 1.1 | Mlig455_036196 | Neo: - Age: - |
1.658 | - | - | - | 0.706 | - | 0.952 | Mlig455_036196 {REF} {Length: 840} {NoTransDecoderORF} {RNA1310_62519} | |
8. | MligTC455_48591 | 25 | 0.53 | Mlig455_047514, Mlig455_059649 | Neo: - Age: - |
NEUROD1 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_047514 {REF} {Length: 1271} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=54.8]; Neuronal helix-loop-helix transcription factor [PF12533.10, score=51.0]} {Human: ENSG00000162992, NEUROD1, neuronal differentiation 1, [Score=140, Expect=1e-38]; ENSG00000164600, NEUROD6, neuronal differentiation 6, [Score=136, Expect=1e-37]} {Mouse: ENSMUSG00000034701, Neurod1, neurogenic differentiation 1, [Score=139, Expect=1e-38]; ENSMUSG00000037984, Neurod6, neurogenic differentiation 6, [Score=133, Expect=1e-36]} {Dmel: FBgn0010433, ato, atonal, [Score=82.0, Expect=8e-18]} {Celegans: WBGene00000561, cnd-1, Neurogenic differentiation factor 1, [Score=127, Expect=6e-36]} {Smed: dd_Smed_v6_21717_0_1, dd_Smed_v6_21717_0_1, [RH, Score=136, Expect=2e-39]} {RNA1310_133631} {RNA815_38093} Mlig455_059649 {REF} {Length: 945} {Pfam: Neuronal helix-loop-helix transcription factor [PF12533.10, score=20.2]} {RNA1310_133631} {RNA815_38093} |
9. | MligTC455_23808 | 31 | 0.65 | Mlig455_059306 | Neo: - Age: Down-Down-Up |
0.981 | - | - | - | - | - | 0.981 | Mlig455_059306 {REF} {Length: 1845} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=30.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} | |
10. | MligTC455_17377 | 32 | 0.67 | Mlig455_041286 | Neo: - Age: - |
0.98 | - | - | - | - | - | 0.980 | Mlig455_041286 {REF} {Length: 912} {NoTransDecoderORF} {RNA1310_106511} | |
11. | MligTC455_16142 | 67 | 1.41 | Mlig455_028937 | Neo: - Age: - |
0.978 | - | - | - | - | - | 0.978 | Mlig455_028937 {REF} {Length: 2115} {NoTransDecoderORF} {RNA1509_53775} {RNA1310_26215.1, RNA1509_53775} {RNA1509_53775, RNA815_54266} | |
12. | MligTC455_19124 | 68 | 1.41 | Mlig455_056714 | Neo: - Age: Up-Down-Up |
NPFFR1 | 0.978 | - | - | - | - | - | 0.978 | Mlig455_056714 {REF} {Length: 3702} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=113.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=90.1, Expect=1e-18]; ENSG00000137252, HCRTR2, hypocretin receptor 2, [Score=87.8, Expect=6e-18]} {Mouse: ENSMUSG00000038071, Npy6r, neuropeptide Y receptor Y6, [Score=105, Expect=2e-24]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=131, Expect=7e-33]} {Celegans: WBGene00003808, npr-2, NeuroPeptide Receptor family, [Score=100, Expect=1e-22]} {Smed: dd_Smed_v6_26109_0_1, dd_Smed_v6_26109_0_1, [RH, Score=210, Expect=4e-61]} {RNA1509_34547} {RNA1310_9062, RNA1509_34547} {RNA1509_34547, RNA815_6805} |
13. | MligTC455_28130 | 73 | 1.52 | Mlig455_017884 | Neo: - Age: - |
0.978 | - | - | - | - | - | 0.978 | Mlig455_017884 {REF} {Length: 3157} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} | |
14. | MligTC455_35879 | 70 | 1.45 | Mlig455_043343 | Neo: - Age: - |
NR4A3 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_043343 {REF} {Length: 4323} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=109.8]} {Human: ENSG00000119508, NR4A3, nuclear receptor subfamily 4 group A member 3, [RH, Score=168, Expect=1e-44]} {Mouse: ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=173, Expect=2e-45]; ENSMUSG00000028341, Nr4a3, nuclear receptor subfamily 4, group A, member 3, [Score=167, Expect=5e-43]} {Dmel: FBgn0014859, Hr38, Hormone receptor-like in 38, [Score=157, Expect=2e-39]} {Celegans: WBGene00003605, nhr-6, Nuclear hormone receptor family member nhr-6, [Score=148, Expect=6e-38]} {Smed: dd_Smed_v6_12229_0_1, dd_Smed_v6_12229_0_1, [Score=236, Expect=5e-66]} {RNA1509_34082, RNA1509_57832} {RNA1310_20528.1, RNA1509_57832} {RNA1509_57832, RNA815_30713} |
15. | MligTC455_44647 | 489 | 10.19 | Mlig455_006279 | Neo: - Age: - |
OXSR1 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_006279 {REF} {Length: 2340} {Pfam: Protein kinase domain [PF00069.27, score=128.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=97.0]; Phosphotransferase enzyme family [PF01636.25, score=18.9]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=18.9]; Fungal protein kinase [PF17667.3, score=18.8]} {Human: ENSG00000172939, OXSR1, oxidative stress responsive 1, [Score=89.7, Expect=2e-18]; ENSG00000091436, MAP3K20, mitogen-activated protein kinase kinase kinase 20, [Score=87.0, Expect=1e-17]; ENSG00000135341, MAP3K7, mitogen-activated protein kinase kinase kinase 7, [Score=85.5, Expect=4e-17]} {Mouse: ENSMUSG00000036737, Oxsr1, oxidative-stress responsive 1, [Score=89.7, Expect=1e-18]; ENSMUSG00000028284, Map3k7, mitogen-activated protein kinase kinase kinase 7, [Score=85.5, Expect=3e-17]} {Dmel: FBgn0046689, Takl1, Tak1-like 1, [Score=86.7, Expect=4e-18]} {Celegans: WBGene00006971, zak-1, Mammalian ZAK kinase homolog, [Score=82.0, Expect=3e-16]} {Smed: dd_Smed_v6_2589_0_2, dd_Smed_v6_2589_0_2, [Score=100, Expect=1e-22]} {RNA1509_40362, RNA1509_48119, RNA1509_54731} {RNA1310_1875.2, RNA1509_40362, RNA1509_48119, RNA1509_54731} {RNA1509_40362, RNA1509_48119, RNA1509_54731, RNA815_820} |
16. | MligTC455_11171 | 38 | 0.79 | Mlig455_032767 | Neo: - Age: - |
0.974 | - | - | - | - | - | 0.974 | Mlig455_032767 {REF} {Length: 428} {TRANSSPLICED} | |
17. | MligTC455_34066 | 149 | 3.1 | Mlig455_069292 | Neo: - Age: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_069292 {REF} {Length: 832} {NoTransDecoderORF} {RNA1509_20753} {RNA1310_16791} {RNA815_12674.1} | |
18. | MligTC455_44281 | 456 | 9.5 | Mlig455_068996 | Neo: - Age: - |
ANPEP | 0.973 | - | - | - | - | - | 0.973 | Mlig455_068996 {REF} {Length: 3001} {Pfam: Peptidase family M1 domain [PF01433.22, score=209.7]; ERAP1-like C-terminal domain [PF11838.10, score=183.2]; Peptidase M1 N-terminal domain [PF17900.3, score=52.5]} {Human: ENSG00000166825, ANPEP, alanyl aminopeptidase, membrane, [Score=234, Expect=6e-66]; ENSG00000141279, NPEPPS, aminopeptidase puromycin sensitive, [Score=232, Expect=2e-65]; ENSG00000138792, ENPEP, glutamyl aminopeptidase, [Score=229, Expect=2e-64]; ENSG00000164308, ERAP2, endoplasmic reticulum aminopeptidase 2, [Score=228, Expect=9e-64]; ENSG00000164307, ERAP1, endoplasmic reticulum aminopeptidase 1, [Score=227, Expect=2e-63]} {Mouse: ENSMUSG00000001441, Npepps, aminopeptidase puromycin sensitive, [Score=232, Expect=4e-67]; ENSMUSG00000023845, Lnpep, leucyl/cystinyl aminopeptidase, [Score=226, Expect=5e-63]; ENSMUSG00000028024, Enpep, glutamyl aminopeptidase, [Score=226, Expect=2e-66]; ENSMUSG00000021583, Erap1, endoplasmic reticulum aminopeptidase 1, [Score=224, Expect=1e-62]; ENSMUSG00000039062, Anpep, alanyl (membrane) aminopeptidase, [Score=223, Expect=3e-62]} {Dmel: FBgn0039656, CG11951, [Score=283, Expect=1e-84]} {Celegans: WBGene00011587, T07F10.1, Aminopeptidase, [Score=215, Expect=1e-59]} {Smed: dd_Smed_v6_6470_0_1, dd_Smed_v6_6470_0_1, [Score=256, Expect=5e-74]} {RNA1509_48214, RNA1509_6569} {RNA1310_3710.1, RNA1509_48214} {RNA1509_48214, RNA815_5591.1} |
19. | MligTC455_44421 | 36 | 0.74 | Mlig455_016824 | Neo: - Age: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_016824 {REF} {Length: 717} {NoTransDecoderORF} {RNA1310_130476} | |
20. | MligTC455_32033 | 79 | 1.65 | Mlig455_050881 | Neo: - |
MAPK14 | 0.972 | - | - | - | - | - | 0.972 | Mlig455_050881 {REF} {Length: 2379} {Pfam: Protein kinase domain [PF00069.27, score=60.5]} {Human: ENSG00000112062, MAPK14, mitogen-activated protein kinase 14, [Score=92.4, Expect=1e-21]; ENSG00000050748, MAPK9, mitogen-activated protein kinase 9, [Score=91.3, Expect=3e-21]; ENSG00000156711, MAPK13, mitogen-activated protein kinase 13, [Score=88.2, Expect=4e-20]} {Mouse: ENSMUSG00000053436, Mapk14, mitogen-activated protein kinase 14, [Score=92.0, Expect=1e-21]; ENSMUSG00000020366, Mapk9, mitogen-activated protein kinase 9, [Score=91.3, Expect=2e-21]} {Dmel: FBgn0024846, p38b, p38b MAP kinase, [Score=90.5, Expect=3e-21]} {Celegans: WBGene00004055, pmk-1, Mitogen-activated protein kinase pmk-1, [Score=86.3, Expect=6e-20]} {Smed: dd_Smed_v6_6042_0_1, dd_Smed_v6_6042_0_1, [Score=87.8, Expect=1e-20]} {RNA1509_37050} {RNA1310_4000} {RNA815_17615} |
21. | MligTC455_07006 | 53 | 1.11 | Mlig455_009073 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_009073 {REF} {Length: 1805} {NoTransDecoderORF} {RNA1509_56630} {RNA1310_27227, RNA1509_56630} {RNA1509_56630, RNA815_16347} | |
22. | MligTC455_32436 | 43 | 0.91 | Mlig455_025074 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_025074 {REF} {Length: 2851} {RNA1509_1845} {RNA1310_50.1} {RNA815_5933} | |
23. | MligTC455_30249 | 100 | 2.09 | Mlig455_009659, Mlig455_048381 | Neo: - Age: - |
0.969 | - | - | - | - | - | 0.969 | Mlig455_009659 {REF} {Length: 3024} {Pfam: Primase C terminal 2 (PriCT-2) [PF08707.13, score=46.3]} {RNA1509_20194} {RNA1310_3607.1} {RNA815_37227} Mlig455_048381 {REF} {Length: 832} {RNA1509_33034} {RNA1310_614.1} {RNA815_31436} |
|
24. | MligTC455_37105 | 54 | 1.13 | Mlig455_057732 | Neo: - Age: - |
ANGPTL1 | 0.967 | - | - | - | - | - | 0.967 | Mlig455_057732 {REF} {Length: 2404} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=107.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.7, Expect=8e-21]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=90.9, Expect=1e-19]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=92.8, Expect=2e-20]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=90.9, Expect=9e-20]} {Dmel: FBgn0050280, CG30280, [Score=88.6, Expect=6e-20]} {Celegans: WBGene00017013, ensh-1, [Score=61.6, Expect=2e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=85.1, Expect=5e-18]} {RNA1509_49031} {RNA1310_45132} {RNA815_44160} |
25. | MligTC455_23606 | 40 | 0.83 | Mlig455_045820 | Neo: - |
ANK2 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_045820 {REF} {Length: 6904} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=588.6]; Ankyrin repeats (many copies) [PF13637.8, score=559.7]; Ankyrin repeat [PF13606.8, score=378.6]; Ankyrin repeats (many copies) [PF13857.8, score=364.4]; Ankyrin repeat [PF00023.32, score=287.1]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=234, Expect=4e-61]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=234, Expect=4e-62]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=208, Expect=1e-53]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=187, Expect=7e-48]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=234, Expect=2e-63]} {RNA1509_19596} {RNA1310_2241.1} {RNA815_5124} |
26. | MligTC455_27488 | 79 | 1.65 | Mlig455_006237 | Neo: - Age: Down-Up-Down |
ANKRD17 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_006237 {REF} {Length: 4623} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=203.3]; Ankyrin repeats (many copies) [PF13637.8, score=140.3]; Ankyrin repeat [PF13606.8, score=112.1]; Ankyrin repeat [PF00023.32, score=88.7]; Ankyrin repeats (many copies) [PF13857.8, score=87.3]; Mab-21 protein [PF03281.16, score=42.5]; Transcription factor BRX N-terminal domain [PF13713.8, score=27.4]} {Human: ENSG00000132466, ANKRD17, ankyrin repeat domain 17, [Score=134, Expect=4e-31]} {Mouse: ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=135, Expect=2e-31]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=99.0, Expect=2e-20]} {Celegans: WBGene00012124, T28D6.4, [Score=92.8, Expect=7e-19]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=127, Expect=2e-29]} {RNA1509_27730, RNA1509_51137} {RNA1310_4721, RNA1509_51137} {RNA1509_51137, RNA815_2426.1} |
27. | MligTC455_36185 | 71 | 1.48 | Mlig455_035985 | Neo: - Age: - |
KCNH7 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_035985 {REF} {Length: 3355} {Pfam: Ion transport protein [PF00520.33, score=118.6]; Ion channel [PF07885.18, score=46.2]; PAS domain [PF13426.9, score=44.5]; Cyclic nucleotide-binding domain [PF00027.31, score=43.8]; PAS fold [PF00989.27, score=22.5]; PAS fold [PF08447.14, score=21.9]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=795, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=786, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=773, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=795, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=794, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=774, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=714, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=775, Expect=0.0]} {RNA1509_16542} {RNA1310_5129.1} {RNA815_4089.1} |
28. | MligTC455_46970 | 116 | 2.42 | Mlig455_023542, Mlig455_023648 | Neo: - Age: Up-Down-Down |
0.966 | - | - | - | - | - | 0.966 | Mlig455_023542 {REF} {Length: 204} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_51411} {RNA1310_6238} {RNA815_21168} Mlig455_023648 {REF} {Length: 217} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_51411} {RNA1310_6238} {RNA815_21168} |
|
29. | MligTC455_19119 | 48 | 0.99 | Mlig455_060984 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_060984 {REF} {Length: 533} {NoTransDecoderORF} {RNA1509_52549} | |
30. | MligTC455_38114 | 228 | 4.74 | Mlig455_012774, Mlig455_070139 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_012774 {REF} {Length: 1873} {NoTransDecoderORF} {RNA1509_58500} {RNA1310_34010} {RNA815_56430} Mlig455_070139 {REF} {Length: 863} {NoTransDecoderORF} {RNA1509_58500} {RNA1310_49425} {RNA815_65230} |
|
31. | MligTC455_18247 | 30 | 0.63 | Mlig455_064217 | Neo: - Age: - |
RASEF | 0.964 | - | - | - | - | - | 0.964 | Mlig455_064217 {REF} {Length: 2591} {Pfam: Ras family [PF00071.24, score=148.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=96.7]; ADP-ribosylation factor family [PF00025.23, score=52.9]; EF-hand domain pair [PF13499.8, score=33.8]; EF-hand domain [PF13405.8, score=31.5]; EF hand [PF00036.34, score=30.7]; 50S ribosome-binding GTPase [PF01926.25, score=23.7]; Elongation factor Tu GTP binding domain [PF00009.29, score=23.0]; EF hand [PF13202.8, score=20.1]; EF-hand domain pair [PF13833.8, score=18.9]} {Human: ENSG00000165105, RASEF, RAS and EF-hand domain containing, [Score=172, Expect=1e-44]; ENSG00000130038, CRACR2A, calcium release activated channel regulator 2A, [Score=169, Expect=2e-43]} {Mouse: ENSMUSG00000043003, Rasef, RAS and EF hand domain containing, [Score=180, Expect=5e-48]} {Dmel: FBgn0005586, Rab3, [Score=129, Expect=8e-34]} {Celegans: WBGene00016344, rsef-1, Ras and EF-hand domain-containing protein homolog, [Score=174, Expect=7e-46]} {Smed: dd_Smed_v6_12567_0_1, dd_Smed_v6_12567_0_1, [Score=207, Expect=8e-58]} {RNA1310_62867} |
32. | MligTC455_19813 | 128 | 2.67 | Mlig455_023194 | Neo: - Age: Down-Up-Down |
0.964 | - | - | - | - | - | 0.964 | Mlig455_023194 {REF} {Length: 614} {TRANSSPLICED} {RNA1509_45712} {RNA1310_38588.2} {RNA815_23034.1} | |
33. | MligTC455_26645 | 132 | 2.74 | Mlig455_032393, Mlig455_032437 | Neo: - Age: - |
B4GALT1 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_032393 {REF} {Length: 2140} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=128.2]; N-terminal domain of galactosyltransferase [PF02709.16, score=66.3]} {Human: ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=178, Expect=1e-51]} {Mouse: ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=174, Expect=4e-50]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=149, Expect=6e-41]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=166, Expect=2e-47]} {Smed: dd_Smed_v6_12436_0_1, dd_Smed_v6_12436_0_1, [Score=174, Expect=7e-51]} {RNA1310_17913} {RNA815_20156} Mlig455_032437 {REF} {Length: 2249} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=126.3]; N-terminal domain of galactosyltransferase [PF02709.16, score=66.3]} {Human: ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=181, Expect=9e-53]} {Mouse: ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=176, Expect=5e-51]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=149, Expect=6e-41]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=166, Expect=2e-47]} {Smed: dd_Smed_v6_12436_0_1, dd_Smed_v6_12436_0_1, [Score=172, Expect=3e-50]} {RNA1310_17913} {RNA815_20156} |
34. | MligTC455_09509 | 46 | 0.95 | Mlig455_042043 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_042043 {REF} {Length: 1543} {Pfam: SICA C-terminal inner membrane domain [PF12879.9, score=63.2]} {RNA1509_50446} {RNA1310_8738.1} {RNA815_21682.1} | |
35. | MligTC455_33212 | 61 | 1.27 | Mlig455_003428 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_003428 {REF} {Length: 1700} {NoTransDecoderORF} {RNA1509_44389} {RNA1310_14765.1} {RNA815_7155} | |
36. | MligTC455_38059 | 120 | 2.49 | Mlig455_014851 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_014851 {REF} {Length: 6091} {RNA1509_53932} {RNA1310_7589} {RNA815_18106} | |
37. | MligTC455_29145 | 72 | 1.51 | Mlig455_014865 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_014865 {REF} {Length: 3483} {RNA1509_13072} {RNA1310_989.1} {RNA815_1327.1} | |
38. | MligTC455_30121 | 227 | 4.74 | Mlig455_049656 | Neo: - |
ZBED1 | 0.962 | - | - | - | - | - | 0.962 | Mlig455_049656 {REF} {Length: 5385} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792, RNA1509_6537} {RNA1509_6537, RNA815_1502} |
39. | MligTC455_20908 | 268 | 5.58 | Mlig455_000262 | Neo: - Age: Up-Down-Down |
NALCN | 0.961 | - | - | - | - | - | 0.961 | Mlig455_000262 {REF} {Length: 6526} {TRANSSPLICED} {Pfam: Ion transport protein [PF00520.33, score=369.8]; Polycystin cation channel [PF08016.14, score=20.1]} {Human: ENSG00000102452, NALCN, sodium leak channel, non-selective, [Score=1434, Expect=0.0]} {Mouse: ENSMUSG00000000197, Nalcn, sodium leak channel, non-selective, [Score=1439, Expect=0.0]} {Dmel: FBgn0002917, na, narrow abdomen, [Score=1431, Expect=0.0]} {Celegans: WBGene00006809, unc-77, Four domain-type voltage-gated ion channel alpha-1 subunit, [Score=1234, Expect=0.0]} {Smed: dd_Smed_v6_7314_0_1, dd_Smed_v6_7314_0_1, [Score=1574, Expect=0.0]} {RNA1509_7317} {RNA1310_530.1} {RNA815_339.1} |
40. | MligTC455_22282 | 66 | 1.37 | Mlig455_058452 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_058452 {REF} {Length: 5087} {TRANSSPLICED} {Smed: dd_Smed_v6_4268_0_2, dd_Smed_v6_4268_0_2, [Score=72.8, Expect=2e-15]} {RNA1509_21983} {RNA1310_15855} {RNA815_31364} | |
41. | MligTC455_16563 | 99 | 2.06 | Mlig455_024661 | Neo: Germline |
0.959 | - | - | - | - | - | 0.959 | Mlig455_024661 {REF} {Length: 1238} {RNA1509_16913} {RNA1310_34604.1} {RNA815_16687} | |
42. | MligTC455_27095 | 36 | 0.76 | Mlig455_017048 | Neo: - Age: Down-Down-Up |
0.959 | - | - | - | - | - | 0.959 | Mlig455_017048 {REF} {Length: 4611} {Pfam: RNase H [PF00075.26, score=49.9]; Reverse transcriptase-like [PF13456.8, score=22.0]} {RNA1509_31798, RNA1509_33867} {RNA1310_13518, RNA1509_33867} {RNA1509_33867, RNA815_23683} | |
43. | MligTC455_42682 | 45 | 0.93 | Mlig455_010400 | Neo: - Age: - |
0.959 | - | - | - | - | - | 0.959 | Mlig455_010400 {REF} {Length: 1751} {NoTransDecoderORF} {RNA1509_58929} {RNA1310_128448} {RNA815_10390} | |
44. | MligTC455_27161 | 124 | 2.57 | Mlig455_042313, Mlig455_042318 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_042313 {REF} {Length: 232} {NoTransDecoderORF} {RNA1509_3} {RNA1310_851.1} {RNA815_80.1} Mlig455_042318 {REF} {Length: 232} {NoTransDecoderORF} {RNA1509_3} {RNA1310_851.1} {RNA815_80.1} |
|
45. | MligTC455_40137 | 98 | 2.05 | Mlig455_060068 | Neo: - Age: - Region-enriched R2: 4.909/0.02205 |
IDNK | 0.958 | - | - | - | - | - | 0.958 | Mlig455_060068 {REF} {Length: 2173} {TRANSSPLICED} {Pfam: Shikimate kinase [PF01202.24, score=36.3]; AAA domain [PF13671.8, score=30.7]; AAA domain [PF13238.8, score=26.4]; AAA domain [PF13521.8, score=24.3]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.5]; AAA domain [PF13207.8, score=20.8]} {Human: ENSG00000148057, IDNK, IDNK, gluconokinase, [RH, Score=126, Expect=2e-36]} {Mouse: ENSMUSG00000050002, Idnk, idnK gluconokinase homolog (E. coli), [RH, Score=132, Expect=3e-39]} {Celegans: WBGene00017818, F26D11.1, Gluconokinase, [RH, Score=127, Expect=2e-37]} {Smed: dd_Smed_v6_14936_0_1, dd_Smed_v6_14936_0_1, [RH, Score=108, Expect=2e-30]} {RNA1509_45489, RNA1509_48460} {RNA1310_24189, RNA1509_45489} {RNA1509_45489, RNA815_32058} |
46. | MligTC455_09301 | 26 | 0.55 | Mlig455_011440 | Neo: - Age: - Regeneration-upregulated BL: 7.313 Regeneration-enriched BL: 7.313 |
0.957 | - | - | - | - | - | 0.957 | Mlig455_011440 {REF} {Length: 331} {NoTransDecoderORF} {RNA1509_58496} {RNA1310_68696} {RNA815_38510} | |
47. | MligTC455_11951 | 23 | 0.48 | Mlig455_013411 | Neo: - Age: - |
TMEM211 | 0.957 | - | - | - | - | - | 0.957 | Mlig455_013411 {REF} {Length: 1576} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=93.8]} {Human: ENSG00000206069, TMEM211, transmembrane protein 211, [Score=50.4, Expect=5e-07]} {Mouse: ENSMUSG00000041700, Lhfpl1, lipoma HMGIC fusion partner-like 1, [Score=85.1, Expect=2e-19]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [Score=136, Expect=4e-38]} {RNA1310_114675} {RNA815_59257} |
48. | MligTC455_12940 | 24 | 0.5 | Mlig455_019094 | Neo: - Age: logFC(26M/2M)=-1.094 |
ZIC1 | 0.957 | - | - | - | - | - | 0.957 | Mlig455_019094 {REF} {Length: 1831} {Pfam: Zic proteins zinc finger domain [PF18366.3, score=76.3]; Zinc-finger double domain [PF13465.8, score=29.6]; Zinc finger, C2H2 type [PF00096.28, score=23.2]} {Human: ENSG00000152977, ZIC1, Zic family member 1, [Score=167, Expect=1e-47]; ENSG00000043355, ZIC2, Zic family member 2, [Score=166, Expect=3e-46]; ENSG00000156925, ZIC3, Zic family member 3, [Score=163, Expect=8e-46]} {Mouse: ENSMUSG00000036972, Zic4, zinc finger protein of the cerebellum 4, [Score=168, Expect=6e-49]; ENSMUSG00000032368, Zic1, zinc finger protein of the cerebellum 1, [Score=167, Expect=8e-48]; ENSMUSG00000061524, Zic2, zinc finger protein of the cerebellum 2, [Score=166, Expect=2e-46]; ENSMUSG00000067860, Zic3, zinc finger protein of the cerebellum 3, [Score=164, Expect=2e-46]} {Dmel: FBgn0003002, opa, odd paired, [Score=164, Expect=2e-45]} {Celegans: WBGene00004335, ref-2, REgulator of Fusion, [Score=100, Expect=5e-24]} {Smed: dd_Smed_v6_15531_0_1, dd_Smed_v6_15531_0_1, [Score=169, Expect=2e-48]} {RNA1509_12223} {RNA1310_49525, RNA1509_12223} {RNA1509_12223, RNA815_49740} |
49. | MligTC455_14778 | 64 | 1.34 | Mlig455_050609 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_050609 {REF} {Length: 1397} {NoTransDecoderORF} {RNA1509_18097} {RNA1310_120182} {RNA815_14810.1} | |
50. | MligTC455_24711 | 46 | 0.96 | Mlig455_015705 | Neo: - Age: - Regeneration-upregulated BL: 6.967 Regeneration-enriched BL: 6.967 |
0.957 | - | - | - | - | - | 0.957 | Mlig455_015705 {REF} {Length: 1380} {NoTransDecoderORF} {RNA1509_40708} {RNA1310_77515} {RNA815_26884} | |
51. | MligTC455_30120 | 632 | 13.16 | Mlig455_034161, Mlig455_042293, Mlig455_047751 | Neo: - Age: logFC(26M/2M)=0.780 Region-enriched R4: 1.642/0.03663 |
ZBED1 | 0.957 | - | - | - | - | - | 0.957 | Mlig455_034161 {REF} {Length: 2933} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792} {RNA815_1502} Mlig455_042293 {REF} {Length: 2933} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792} {RNA815_1502} Mlig455_047751 {REF} {Length: 2933} {TRANSSPLICED} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=44.1]; BED zinc finger [PF02892.17, score=30.7]} {Human: ENSG00000214717, ZBED1, zinc finger BED-type containing 1, [Score=89.0, Expect=1e-17]} {Mouse: ENSMUSG00000094410, Gm38394, predicted gene, 38394, [Score=59.3, Expect=1e-08]; ENSMUSG00000102049, Zbed6, zinc finger, BED type containing 6, [Score=59.3, Expect=1e-08]} {Smed: dd_Smed_v6_18427_0_1, dd_Smed_v6_18427_0_1, [Score=49.7, Expect=4e-06]} {RNA1509_6537} {RNA1310_5792} {RNA815_1502} |
52. | MligTC455_31201 | 73 | 1.53 | Mlig455_045851, Mlig455_045867 | Neo: - Age: Up-Down-Up |
LRRC9 | 0.957 | - | - | - | - | - | 0.957 | Mlig455_045851 {REF} {Length: 5484} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.6]; Leucine rich repeat [PF13855.8, score=111.6]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=437, Expect=1e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=73.6, Expect=1e-12]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=7e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=368, Expect=4e-108]} {RNA1509_22179} {RNA1310_1731, RNA1509_22179} {RNA1509_22179, RNA815_589.1} Mlig455_045867 {REF} {Length: 5480} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.3]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.0]; Leucine rich repeat [PF13855.8, score=111.3]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=436, Expect=2e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=74.7, Expect=6e-13]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=8e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=369, Expect=2e-108]} {RNA1509_22179} {RNA1310_1731} {RNA815_589.1} |
53. | MligTC455_28340 | 55 | 1.14 | Mlig455_034493, Mlig455_038767, Mlig455_066245 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.182/0.03406 |
CHRNB3, PCDH9 | 0.956 | - | - | - | - | - | 0.956 | Mlig455_034493 {REF} {Length: 1601} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=158.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=91.2]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=204, Expect=4e-59]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=202, Expect=4e-58]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=195, Expect=1e-55]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=194, Expect=2e-55]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=194, Expect=3e-54]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=206, Expect=5e-60]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=200, Expect=2e-57]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=190, Expect=8e-54]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=185, Expect=1e-52]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=370, Expect=4e-122]} {RNA1509_55679} {RNA1310_29798} {RNA815_45190} Mlig455_038767 {REF} {Length: 4472} {Pfam: Cadherin domain [PF00028.19, score=325.9]; Cadherin-like [PF16184.7, score=44.8]; Cadherin-like [PF08266.14, score=40.4]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [RH, Score=339, Expect=1e-98]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [RH, Score=335, Expect=2e-97]} {Dmel: FBgn0024836, stan, starry night, [Score=248, Expect=4e-67]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=214, Expect=3e-56]} {Smed: dd_Smed_v6_11633_0_1, dd_Smed_v6_11633_0_1, [RH, Score=355, Expect=2e-105]} {RNA1509_51596} {RNA1310_4295, RNA1509_51596} {RNA1509_51596, RNA815_10391} Mlig455_066245 {REF} {Length: 3076} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=159.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.6]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=208, Expect=1e-60]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=207, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=202, Expect=4e-57]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=202, Expect=2e-58]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=3e-57]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=198, Expect=1e-56]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=210, Expect=2e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=206, Expect=1e-59]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=201, Expect=2e-56]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=201, Expect=4e-58]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=201, Expect=9e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=187, Expect=3e-53]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=424, Expect=6e-143]} {RNA1509_55679} {RNA1310_29798, RNA1509_55679} {RNA1509_55679, RNA815_45190} |
54. | MligTC455_36485 | 54 | 1.13 | Mlig455_019921, Mlig455_059996, Mlig455_060437 | Neo: - Age: - |
0.956 | - | - | - | - | - | 0.956 | Mlig455_019921 {REF} {Length: 215} {NoTransDecoderORF} {RNA1509_26293} {RNA1310_22958} {RNA815_52664} Mlig455_059996 {REF} {Length: 1701} {NoTransDecoderORF} {RNA1509_26293} {RNA1310_22958} {RNA815_52664} Mlig455_060437 {REF} {Length: 4172} {NoTransDecoderORF} {RNA1509_55514} {RNA1310_37194} {RNA815_10967.1} |
|
55. | MligTC455_51319 | 50 | 1.04 | Mlig455_050267 | Neo: - Age: - Region-enriched R4: 4.268/0.03200 |
RAD51C | 0.956 | - | - | - | - | - | 0.956 | Mlig455_050267 {REF} {Length: 1379} {TRANSSPLICED} {Pfam: Rad51 [PF08423.13, score=138.4]; AAA domain [PF13481.8, score=35.5]; KaiC [PF06745.15, score=18.8]} {Human: ENSG00000108384, RAD51C, RAD51 paralog C, [RH, Score=179, Expect=3e-52]} {Mouse: ENSMUSG00000007646, Rad51c, RAD51 paralog C, [RH, Score=179, Expect=1e-52]} {Dmel: FBgn0003482, spn-D, spindle D, [RH, Score=110, Expect=1e-27]} {Celegans: WBGene00004297, rad-51, RAD51 short isoform; RecA/Rad51/Dmc1-like protein, [Score=70.5, Expect=3e-13]} {Smed: dd_Smed_v6_16724_0_2, dd_Smed_v6_16724_0_2, [RH, Score=183, Expect=3e-55]} {RNA1509_27617} {RNA1310_25633.1, RNA1509_27617} {RNA1509_27617, RNA815_20829} |
56. | MligTC455_10086 | 82 | 1.7 | Mlig455_024870 | Neo: - Age: logFC(26M/2M)=0.239 |
0.955 | - | - | - | - | - | 0.955 | Mlig455_024870 {REF} {Length: 2906} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF5054) [PF16477.7, score=80.4]} {Smed: dd_Smed_v6_540_0_1, dd_Smed_v6_540_0_1, [RH, Score=494, Expect=3e-164]} {RNA1509_50537} {RNA1310_4754} {RNA815_1397.1} | |
57. | MligTC455_32435 | 68 | 1.42 | Mlig455_025058 | Neo: - |
0.955 | - | - | - | - | - | 0.955 | Mlig455_025058 {REF} {Length: 6341} {Mouse: ENSMUSG00000043183, Simc1, SUMO-interacting motifs containing 1, [Score=58.2, Expect=1e-07]} {RNA1509_27520, RNA1509_33149, RNA1509_59656} {RNA1310_50.1, RNA1509_27520, RNA1509_33149, RNA1509_59656} {RNA1509_27520, RNA1509_33149, RNA1509_59656, RNA815_5201} | |
58. | MligTC455_11576 | 215 | 4.49 | Mlig455_045740 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_045740 {REF} {Length: 672} {NoTransDecoderORF} {RNA1509_6409} {RNA1310_984} {RNA815_7594.1} | |
59. | MligTC455_24825 | 105 | 2.19 | Mlig455_011292 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_011292 {REF} {Length: 3653} {RNA1509_43125} {RNA1310_9297, RNA1509_43125} {RNA1509_43125, RNA815_39862} | |
60. | MligTC455_25309 | 27 | 0.56 | Mlig455_007405 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_007405 {REF} {Length: 5652} {RNA1509_20101} {RNA1310_66411} {RNA815_42952} | |
61. | MligTC455_33089 | 33 | 0.69 | Mlig455_016570 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_016570 {REF} {Length: 1723} {RNA1509_27637} {RNA1310_33309} {RNA815_11183} | |
62. | MligTC455_16032 | 77 | 1.61 | Mlig455_037337 | Neo: Irradiation |
0.952 | - | - | - | - | - | 0.952 | Mlig455_037337 {REF} {Length: 3079} {Pfam: Neuralized [PF07177.14, score=30.4]} {RNA1310_49372} | |
63. | MligTC455_23568 | 23 | 0.47 | Mlig455_061665 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_061665 {REF} {Length: 1787} {NoTransDecoderORF} {RNA1509_10924} {RNA1310_115958} {RNA815_9399} | |
64. | MligTC455_25567 | 31 | 0.65 | Mlig455_003495, Mlig455_015560, Mlig455_037973 | Neo: - Age: - |
GLRA4 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_003495 {REF} {Length: 2067} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431} Mlig455_015560 {REF} {Length: 1799} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431} Mlig455_037973 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.4]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.5, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=57.4, Expect=2e-08]} {Mouse: ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.5, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_2, dd_Smed_v6_14925_0_2, [Score=554, Expect=0.0]} {RNA1310_35073.2} {RNA815_40431} |
65. | MligTC455_28935 | 350 | 7.3 | Mlig455_001893 | Neo: Int S/G2/M Age: logFC(26M/2M)=-0.374 |
0.952 | - | - | - | - | - | 0.952 | Mlig455_001893 {REF} {Length: 1894} {Pfam: Universal stress protein family [PF00582.28, score=78.8]} {Smed: dd_Smed_v6_1092_0_1, dd_Smed_v6_1092_0_1, [Score=112, Expect=2e-32]} {RNA1509_16808, RNA1509_2764, RNA1509_31626} {RNA1310_13748, RNA1509_16808, RNA1509_31626} {RNA1509_16808, RNA1509_31626, RNA815_17818.1} | |
66. | MligTC455_34907 | 179 | 3.73 | Mlig455_044103 | Neo: - Age: logFC(26M/2M)=0.902 |
SLC22A15 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_044103 {REF} {Length: 2798} {Pfam: Sugar (and other) transporter [PF00083.26, score=91.9]; Major Facilitator Superfamily [PF07690.18, score=46.0]} {Human: ENSG00000163393, SLC22A15, solute carrier family 22 member 15, [Score=95.5, Expect=2e-21]; ENSG00000172940, SLC22A13, solute carrier family 22 member 13, [Score=94.7, Expect=5e-21]} {Mouse: ENSMUSG00000067144, Slc22a7, solute carrier family 22 (organic anion transporter), member 7, [Score=98.6, Expect=1e-22]} {Dmel: FBgn0086365, Orct2, Organic cation transporter 2, [Score=123, Expect=2e-31]} {Celegans: WBGene00003843, oct-2, Organic Cation Transporter; Organic cation transporter, [Score=97.4, Expect=3e-22]} {Smed: dd_Smed_v6_10903_0_1, dd_Smed_v6_10903_0_1, [Score=133, Expect=2e-35]} {RNA1509_47816} {RNA1310_3637.2, RNA1509_47816} {RNA1509_47816, RNA815_23449} |
67. | MligTC455_42677 | 249 | 5.18 | Mlig455_020476 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_020476 {REF} {Length: 1858} {TRANSSPLICED} {RNA1509_34250} {RNA1310_13323} {RNA815_20547} | |
68. | MligTC455_43912 | 108 | 2.26 | Mlig455_038979 | Neo: - Age: - Region-enriched R8: 3.794/0.00970 |
SNAI2 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_038979 {REF} {Length: 2442} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=89.3]; C2H2-type zinc finger [PF13894.8, score=57.9]; Zinc-finger double domain [PF13465.8, score=53.2]; Zinc-finger of C2H2 type [PF12874.9, score=40.2]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=40.0]; C2H2-type zinc finger [PF13912.8, score=35.8]; C2HE / C2H2 / C2HC zinc-binding finger [PF16278.7, score=24.6]; Zinc ribbon domain [PF09723.12, score=19.4]} {Human: ENSG00000019549, SNAI2, snail family transcriptional repressor 2, [RH, Score=204, Expect=3e-62]} {Mouse: ENSMUSG00000022676, Snai2, snail family zinc finger 2, [RH, Score=202, Expect=6e-62]} {Dmel: FBgn0001983, wor, worniu, [RH, Score=207, Expect=7e-61]} {Celegans: WBGene00019299, snai-1, SNAIl family zinc finger 2 transcription factor homolog, [Score=152, Expect=9e-44]} {Smed: dd_Smed_v6_10216_0_1, dd_Smed_v6_10216_0_1, [RH, Score=204, Expect=3e-62]} {RNA1509_43471} {RNA1310_64158} {RNA815_60731} |
69. | MligTC455_11282 | 124 | 2.58 | Mlig455_017457, Mlig455_030936 | Neo: - |
FDXACB1 | 0.951 | - | - | - | - | - | 0.951 | Mlig455_017457 {REF} {Length: 3560} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=28.8]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=1e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=4e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1509_12220} {RNA1310_10541} {RNA815_15665} Mlig455_030936 {REF} {Length: 2975} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=29.2]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=2e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=6e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1310_10541} {RNA815_15665} |
70. | MligTC455_13733 | 48 | 1.01 | Mlig455_060487 | Neo: - Age: - |
0.951 | - | - | - | - | - | 0.951 | Mlig455_060487 {REF} {Length: 1932} {RNA1310_31419} {RNA815_30794} | |
71. | MligTC455_18799 | 47 | 0.98 | Mlig455_031256, Mlig455_031302 | Neo: - Age: - |
0.951 | - | - | - | - | - | 0.951 | Mlig455_031256 {REF} {Length: 1098} Mlig455_031302 {REF} {Length: 1102} |
|
72. | MligTC455_08198 | 26 | 0.55 | Mlig455_045449 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_045449 {REF} {Length: 411} {RNA1310_123580} {RNA815_47103} | |
73. | MligTC455_12197 | 252 | 5.26 | Mlig455_017087 | Neo: - Age: Down-Down-Up Region-enriched R5: 1.888/0.03999 |
CXorf65 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_017087 {REF} {Length: 1998} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=80.7]} {Human: ENSG00000204165, CXorf65, chromosome X open reading frame 65, [Score=45.8, Expect=5e-06]} {Mouse: ENSMUSG00000090141, Gm614, predicted gene 614, [Score=48.9, Expect=3e-07]} {RNA1509_30706} {RNA1310_4498.2} {RNA815_1649} |
74. | MligTC455_31582 | 52 | 1.09 | Mlig455_041960 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_041960 {REF} {Length: 1624} {TRANSSPLICED} {Pfam: Soluble NSF attachment protein, SNAP [PF14938.8, score=59.0]} {RNA1509_49446} {RNA1310_31757} {RNA815_11744} | |
75. | MligTC455_34065 | 155 | 3.22 | Mlig455_057127 | Neo: - Age: Up-Down-Up |
0.95 | - | - | - | - | - | 0.950 | Mlig455_057127 {REF} {Length: 9700} {RNA1509_19375, RNA1509_20753, RNA1509_27043, RNA1509_49996} {RNA1310_9943, RNA1509_20753, RNA1509_27043, RNA1509_49996} {RNA1509_20753, RNA1509_27043, RNA1509_49996, RNA815_25153} | |
76. | MligTC455_54026 | 99 | 2.07 | Mlig455_025843, Mlig455_025903 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_025843 {REF} {Length: 2505} {TRANSSPLICED} {Pfam: Hsp20/alpha crystallin family [PF00011.23, score=91.5]; HSP20-like domain found in ArsA [PF17886.3, score=30.3]} {Dmel: FBgn0001225, Hsp26, Heat shock protein 26, [RH, Score=57.8, Expect=8e-10]} {Celegans: WBGene00008592, F08H9.4, [RH, Score=60.5, Expect=2e-11]} {Smed: dd_Smed_v6_1039_0_1, dd_Smed_v6_1039_0_1, [RH, Score=101, Expect=2e-25]} {RNA1509_26837} {RNA1310_48105} {RNA815_21766} Mlig455_025903 {REF} {Length: 2459} {TRANSSPLICED} {Pfam: Hsp20/alpha crystallin family [PF00011.23, score=91.5]; HSP20-like domain found in ArsA [PF17886.3, score=30.3]} {Dmel: FBgn0001225, Hsp26, Heat shock protein 26, [RH, Score=57.8, Expect=8e-10]} {Celegans: WBGene00008592, F08H9.4, [RH, Score=60.8, Expect=2e-11]} {Smed: dd_Smed_v6_1039_0_1, dd_Smed_v6_1039_0_1, [RH, Score=101, Expect=2e-25]} {RNA1509_33990} {RNA1310_42388.1} {RNA815_21766} |